Compound 1750
Identifiers
- Canonical SMILES:
O[C@@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccn1
- IUPAC name:
4-(3-{4-[cyclopentyl(hydroxy)pyridin-2-ylmethyl]piperidin-1-yl}propoxy)benzonitrile
- InChi:
InChI=1S/C26H33N3O2/c27-20-21-9-11-24(12-10-21)31-19-5-16-29-17-13-23(14-18-29)26(30,22-6-1-2-7-22)25-8-3-4-15-28-25/h3-4,8-12,15,22-23,30H,1-2,5-7,13-14,16-19H2/t26-/m0/s1
- InChiKey:
CXFJNJZPBYIKCK-SANMLTNESA-N
External links
![]() 71777739 |
![]() CHEMBL3126201 |
2S7 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MENIN / MLL | 6.52 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 419.26 g/mol | |||
HBA | 5 | |||
HBD | 1 | |||
HBA + HBD | 6 | |||
AlogP | 4.07 | |||
TPSA | 69.38 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6200 | Dianicline | DB12125 | |
0.5390 | Hydroquinine | DB13718 | |
0.5390 | Hydroquinidine | DB15300 | |
0.5067 | Quinine | DB00468 | |
0.5067 | Quinidine | DB00908 | |
0.5034 | SCH-486757 | DB12782 | |
0.4967 | Bepotastine | DB04890 | |
0.4960 | Tramadol | DB00193 | |
0.4957 | Cycrimine | DB00942 | |
0.4857 | KH064 | DB04287 | |
0.4830 | Trihexyphenidyl | DB00376 | |
0.4817 | GDC-0425 | DB14791 | |
0.4804 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4798 | Oliceridine | DB14881 | |
0.4797 | Quinisocaine | DB13683 |